Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has issued an announcement.
Daito Pharmaceutical Co., Ltd. has completed the acquisition of 242,000 treasury shares, equivalent to 0.8% of its total shares, as part of its capital policy to enhance shareholder returns and improve capital efficiency. The company plans to cancel these shares by May 2026, which will reduce the total number of shares issued, potentially impacting shareholder value and market perception.
The most recent analyst rating on (JP:4577) stock is a Hold with a Yen1261.00 price target. To see the full list of analyst forecasts on Daito Pharmaceutical Co., Ltd. stock, see the JP:4577 Stock Forecast page.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 72,180
Technical Sentiment Signal: Buy
Current Market Cap: Yen35.63B
For detailed information about 4577 stock, go to TipRanks’ Stock Analysis page.